SCHEMBL18210792

SCHEMBL18210792

COC(=O)c1ccc(CC2CC[C@H]([C@H](O[Si](C)(C)C(C)(C)C)c3ccc(Cl)nc3)N2C(=O)OC(C)(C)C)cc1

nearest known ligand 0.38

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
HDAC1 Q13547 1/20 0.38
HDAC6 Q9UBN7 1/20 0.38
TP53 P04637 1/20 0.34
MAPT P10636 1/20 0.34
THRB P10828 1/20 0.34
CHRNB2 P17787 1/20 0.32
CHRNA7 P36544 1/20 0.32
CHRNA4 P43681 1/20 0.32
KDM4D Q6B0I6 1/20 0.32
PKM P14618 1/20 0.32
KDM4E B2RXH2 2/20 0.31
HSD17B10 Q99714 1/20 0.31
CETP P11597 2/20 0.31
CNR1 P21554 1/20 0.31
GPR119 Q8TDV5 1/20 0.31
CYP3A4 P08684 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17986558 1.00 HDAC1 (0.38) HDAC1HDAC6TP53MAPTTHRB
SCHEMBL16629717 1.00 HDAC1 (0.38) HDAC1HDAC6TP53MAPTTHRB
SCHEMBL16618957 1.00 HDAC1 (0.38) HDAC1HDAC6TP53MAPTTHRB
SCHEMBL18017427 0.92 ADRB1 (0.34) HDAC1CHRNB2CHRNA7CHRNA4HSD17B10
SCHEMBL21278534 0.92 ADRB1 (0.34) HDAC1CHRNB2CHRNA7CHRNA4HSD17B10
SCHEMBL16619734 0.92 ADRB1 (0.34) HDAC1CHRNB2CHRNA7CHRNA4HSD17B10
SCHEMBL21268138 0.92 ADRB1 (0.34) HDAC1CHRNB2CHRNA7CHRNA4HSD17B10
SCHEMBL21278308 0.92 ADRB1 (0.34) HDAC1CHRNB2CHRNA7CHRNA4HSD17B10
SCHEMBL18017469 0.92 ADRB1 (0.34) HDAC1CHRNB2CHRNA7CHRNA4HSD17B10
SCHEMBL16619958 0.92 ADRB1 (0.34) HDAC1CHRNB2CHRNA7CHRNA4HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9486448-B2 Pyrrolidine derived beta 3 adrenergic receptor agonists MERCK SHARP & DOHME CORP. (US) 2016-11-08 US disclosed